I agree that this site is using cookies. You can find further informations here.
X
Pearson, Isobel V
88  results:
Search for persons X
?
1

Erratum to: Cost-effectiveness of febuxostat in chronic gou:

Beard, Stephen M. ; von Scheele, Birgitta G. ; Nuki, George.
The European Journal of Health Economics.  15 (2014)  8 - p. 897-897 , 2014
Link: https://doi.org/10.1007/..
 
?
2

Cost-effectiveness of febuxostat in chronic gout:

Beard, Stephen M. ; von Scheele, Birgitta G. ; Nuki, George.
The European Journal of Health Economics.  15 (2014)  5 - p. 453-463 , 2014
Link: https://www.jstor.org/st..
 
?
3

Cost-effectiveness of febuxostat in chronic gout:

Beard, Stephen M. ; von Scheele, Birgitta G. ; Nuki, George.
The European Journal of Health Economics.  , 2013
Link: https://doi.org/10.1007/..
 
?
4

A Mutant of Paracoccus denitrificans with Disrupted Genes C..:

Pearson, Isobel V ; Page, M. Dudley ; van Spanning, Rob J. M.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC219389.  , 2003
Link: http://www.ncbi.nlm.nih...
 
?
5

Subscapular abscesses: A literature review and evidence-bas..:

McFarlane, Isobel V ; Wong, Marcus ; Alder-Price, Angela Chang
Shoulder & Elbow.  16 (2023)  3 - p. 232-238 , 2023
Link: https://doi.org/10.1177/..
 
?
6

A Systematic Review of Clinical Practice Guidelines for Alz..:

Tahami Monfared, Amir Abbas ; Phan, N. T. Nhan ; Pearson, Isobel...
Neurology and Therapy.  12 (2023)  4 - p. 1257-1284 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L. ; Zhang, Yuanhui...
PharmacoEconomics.  40 (2021)  3 - p. 323-339 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Targeted literature review on use of tumor mutational burde..:

Krieger, Tina ; Pearson, Isobel ; Bell, Judith..
Diagnostic Pathology.  15 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
9

Economic Modeling Considerations for Rare Diseases:

Pearson, Isobel ; Rothwell, Ben ; Olaye, Andrew.
Value in Health.  21 (2018)  5 - p. 515-524 , 2018
Link: https://doi.org/10.1016/..
 
?
10

A cost-effectiveness analysis using real-world data from th..:

Herring, William ; Zhang, Yuanhui ; Pearson, Isobel...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
11

Cost Effectiveness of Ofatumumab Plus Chlorambucil in First..:

Herring, William ; Pearson, Isobel ; Purser, Molly...
PharmacoEconomics.  34 (2015)  1 - p. 77-90 , 2015
Link: https://doi.org/10.1007/..
 
?
12

Protective clothing — The pesticide manufacturer's viewpoin:

Maltby, Isobel V.B.
Journal of Occupational Accidents.  11 (1990)  4 - p. 277-283 , 1990
Link: https://doi.org/10.1016/..
 
?
13

First Africa-based clinical trial for novel type 2 oral pol..:

Cooper, Laura V ; Blake, Isobel M
The Lancet.  403 (2024)  10432 - p. 1113-1115 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Effectiveness of poliovirus vaccines against circulating va..:

Cooper, Laura V ; Erbeto, Tesfaye B ; Danzomo, Abba A...
The Lancet Infectious Diseases.  24 (2024)  4 - p. 427-436 , 2024
Link: https://doi.org/10.1016/..
 
?
15

The Origins and Risk Factors for Serotype-2 Vaccine-Derived..:

Gray, Elizabeth J ; Cooper, Laura V ; Bandyopadhyay, Ananda S..
The Journal of Infectious Diseases.  228 (2023)  1 - p. 80-88 , 2023
Link: https://doi.org/10.1093/..
 
1-15